Valuation: Winston Pharmaceuticals, Inc.

Market Cap	15.48M 13.87M 12.79M 11.58M 21.65M 1.47B 22M 153M 60.89M 772M 58.1M 56.86M 2.44B	P/E 2008	-49.9x	P/E 2009	-6.46x
Enterprise Value	13.92M 12.47M 11.5M 10.41M 19.46M 1.33B 19.78M 137M 54.74M 694M 52.24M 51.12M 2.2B	EV / Sales 2008	572x	EV / Sales 2009	14.4x
Free-Float	100%	Yield 2008 *	-	Yield 2009	-

* Estimated data More valuation ratios

Latest news: Winston Pharmaceuticals, Inc.

09/04/12

Winston Pharmaceuticals, Inc. Receives SBIR Grant from the NIH to Investigate Treatment for Postherpetic Neuralgia of the Trigeminal Nerve

More news

Managers and Directors: Winston Pharmaceuticals, Inc.

Manager	Title	Age	Since
Joel E. Bernstein CEO	Chief Executive Officer	83	19/02/2010

More insiders

Winston Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company discovers, develops and commercializes therapeutics for managing and alleviating pain. The Company's late stage candidates include products for the treatment of episodic cluster headache, chronic migraine headache, osteoarthritis, rheumatoid arthritis, neuropathic pain, and pain and inflammation in inflammatory bowel disease. The Company is developing Civamide, which is a transient receptor potential channels vanilloid-1 (TRPV-1) modulator in different dosage forms for several different pain indications. The Company's other products are under development for the treatment of headache and neuropathic and rheumatological pain.

Employees

Sector

Pharmaceuticals

More about the company

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - OTC Markets 21:20:26 12/07/2023 +04			5-day change	1st Jan Change
0.0900 ^USD	-70.00%		+8,999,900.00%	+89,900.00%

1 day	-70.00%
1 week	+8,999,900.00%
Current month	+8,999,900.00%
1 month	+8,999,900.00%
3 months	+8,999,900.00%
6 months	+8,999,900.00%
Current year	+89,900.00%

Current year	0		0.29
1 year	0		0.29
3 years	0		0.29
5 years	0		0.3
10 years	0		0.3

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WINSTON PHARMACEUTICALS, INC.	-70.00%	+8,999,900.00%	+89,900.00%	+8,999,900.00%	77
ELI LILLY AND COMPANY	+6.63%	+5.13%	+68.86%	+145.20%	1,224B
JOHNSON & JOHNSON	+1.53%	+2.84%	+47.48%	+89.01%	662B
ABBVIE INC.	+1.68%	+1.96%	+29.16%	+109.31%	514B
ROCHE HOLDING AG	+0.73%	+2.45%	+54.26%	+68.96%	388B
MERCK & CO., INC.	+3.83%	-0.62%	+69.01%	+42.32%	361B
NOVARTIS AG	+2.38%	+2.65%	+34.31%	+57.95%	302B
ASTRAZENECA PLC	+2.26%	+0.55%	+3.92%	+28.92%	271B
AMGEN INC.	+1.97%	+3.01%	+57.91%	+76.14%	249B
GILEAD SCIENCES, INC.	+4.03%	+5.36%	+39.76%	+116.14%	205B
Average	-4.89%	+2.33%	+9,030.47%	+900,063.40%	417.68B
Weighted average by Cap.	+2.26%	+3.04%	+50.45%	+96.49%

	2008	2009
Net sales	453K 405K 374K 338K 633K 43.09M 643K 4.46M 1.78M 22.55M 1.7M 1.66M 71.43M	1.39M 1.25M 1.15M 1.04M 1.95M 133M 1.98M 13.75M 5.48M 69.5M 5.23M 5.12M 220M
Net income	-5.14M -4.61M -4.25M -3.84M -7.19M -490M -7.31M -50.69M -20.22M -256M -19.3M -18.89M -812M	-2.66M -2.38M -2.19M -1.99M -3.71M -253M -3.77M -26.18M -10.44M -132M -9.97M -9.75M -419M
Net Debt	-5.63M -5.04M -4.65M -4.21M -7.87M -536M -8M -55.47M -22.13M -280M -21.12M -20.67M -888M	-1.56M -1.4M -1.29M -1.17M -2.19M -149M -2.22M -15.41M -6.15M -77.89M -5.87M -5.74M -247M

Winston Pharmaceuticals, Inc. Stock

Stocks

WPHM

US9756571074

Pharmaceuticals

Valuation: Winston Pharmaceuticals, Inc.

Latest news: Winston Pharmaceuticals, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Winston Pharmaceuticals, Inc.

Other Pharmaceuticals

Financials

Company Profile